AMAG Pharma to snap up stem cell firm for $700 million

AMAG Pharmaceuticals announced on Monday that it will acquire Cord Blood Registry (CBR), the world’s largest stem cell collection and storage company, for $700 million. Currently, CBR stores more than 600,000 umbilical cord blood and tissue stem cell units.

[Read the full article here]

Comments are closed.